Group items tagged

Immune inhibitors are antibodies developed in hemophilia patients. Hemophilia is a hereditary blood-related disorder that occurs due to deficiency or absence of clotting factor VIII (hemophilia A) or clotting factor IX (hemophilia B). The condition can be classified according to amount of clotting factor present although classification is not limited to the type of deficient clotting factor.

Phosphodiesterase enzyme (PDE) inhibitors is a group of anti-inflammatory drugs that can be useful for the treatment of Crohn's disease (CD) and ulcerative colitis, as well as other inflammatory bowel diseases.